Results 151 to 160 of about 16,753 (176)

Safety evaluation of an extension of use of the food enzyme subtilisin from the genetically modified <i>Bacillus licheniformis</i> strain NZYM-CB. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Tokić V, Cavanna D, Liu Y.   +15 more
europepmc   +1 more source

Assessment of genetically modified soybean MON 87769 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21253). [PDF]

EFSA J
EFSA Panel on Genetically Modified Organisms (GMO), Casacuberta J, Barro F, Braeuning A, de Maagd R, Epstein MM, Frenzel T, Gallois JL, Koning F, Messéan A, Moreno FJ, Nogué F, Savoini G, Schulman AH, Tebbe C, Veromann E, Gómez JÁ, Goumperis T, Lenzi P, Camargo AM, Piffanelli P, Raffaello T, Gonzales ABG, Sánchez-Brunete E.   +23 more
europepmc   +1 more source

FAO veterinary vaccine registration: enhancing access to safe and high-quality livestock vaccines for disease control programs and during emergency in countries. [PDF]

One Health Outlook
Cosseddu GM, Qiu Y, Goovaerts D, Metlin A, Blancato D, Maliski S, Tiensin T, Metwally S.   +7 more
europepmc   +1 more source

Safety evaluation of an extension of use of the food enzyme subtilisin from the non-genetically modified <i>Bacillus licheniformis</i> strain NZYM-CX. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Solano MLM, Van Loveren H, Vernis L, Rosell AF, Cavanna D, Liu Y.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Advantages of using an abbreviated dossier for drug master file applications in Taiwan

Regulatory Toxicology and Pharmacology, 2016
I-Chen Sun
exaly  

Considerations for development of an evidence dossier to support the use of mobile sensor technology for clinical outcome assessments in clinical trials

Contemporary Clinical Trials, 2020
Joseph Cappelleri, S Eremenco, J C Cappelleri   +2 more
exaly  

Contribution du dossier pharmaceutique dans l’analyse des interactions médicamenteuses lors de la rétrocession dans un centre de lutte contre le cancer

Annales Pharmaceutiques Francaises, 2023
exaly  

Blair says UK dossier points to Iraq's missile capacity

Lancet, The, 2002
Sarah Ramsay
exaly